Single dose regorafenib-induced hypertensive crisis

• Published in: Experimental Oncology
• Date: 2014
• Main Authors: Yilmaz, B., Kemal, Y., Teker, F., Kut, E., Demirag, G., Yucel, I.
• Format: Article
• Language: English
• Published: Інститут експериментальної патології, онкології і радіобіології ім. Р.Є. Кавецького НАН України 2014
• Subjects: Case report
• Online Access: https://nasplib.isofts.kiev.ua/handle/123456789/145356
• Journal Title: Digital Library of Periodicals of National Academy of Sciences of Ukraine
• Cite this: Single dose regorafenib-induced hypertensive crisis / B. Yilmaz, Y. Kemal, F. Teker, E. Kut, G. Demirag, I. Yucel // Experimental Oncology. — 2014. — Т. 36, № 2. — С. 134-135. — Бібліогр.: 15 назв. — англ.

Gastrointestinal stromal tumors (GISTs) are uncommon tumors of the gastrointestinal (GI) tract. Regorafenib is a new multikinase inhibitor and is approved for the treatment of GISTs in patients who develop resistance to imatinib and sunitinib. The most common drug-related adverse events with regoraf...